Richard Scott Struthers - May 14, 2025 Form 4 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role
President & CEO, Director
Signature
/s/ Tobin Schilke, as attorney-in-fact
Stock symbol
CRNX
Transactions as of
May 14, 2025
Transactions value $
$0
Form type
4
Date filed
5/16/2025, 04:30 PM
Previous filing
Apr 4, 2025
Next filing
Sep 30, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Struthers Richard Scott President & CEO, Director C/O CRINETICS PHARMACEUTICALS, INC., 6055 LUSK BOULEVARD, SAN DIEGO /s/ Tobin Schilke, as attorney-in-fact 2025-05-16 0001746298

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRNX Common Stock Gift $0 -90.4K -22.03% $0.00 320K May 14, 2025 Direct F1
transaction CRNX Common Stock Gift $0 +90.4K +15.84% $0.00 661K May 14, 2025 By Family Trust 1 F1
holding CRNX Common Stock 110K May 14, 2025 By Family Trust 2
holding CRNX Common Stock 110K May 14, 2025 By Family Trust 3
holding CRNX Common Stock 100K May 14, 2025 By Family Trust 4
holding CRNX Common Stock 1K May 14, 2025 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Bona fide gift made by the Reporting person for no consideration.